insiders being insiders. Up until Friday, after market close, $MDGL was the only company with an FDA approved drug to treat MASH. $NVO made headlines after market close with Wegovy now being approved to treat MASH. (1st GLP1 to do so) $MDGL insiders dumped $80m, days prior.
2,46K